 This study aims to estimate vaccine effectiveness against hospitalization with the Armacryne and Delta variants using different definitions of hospitalization in secondary care data, and found reduced effectiveness even after a booster dose for SARS-CoV-2 variants of concern. This article was authored by Julia Stowe, Nick Andrews, Frigia Kirspam, and others.